🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease

RecruitingPhase 2Ages 18 Years - 80 YearsAllGuy's and St Thomas' NHS Foundation Trust
NCT06339580 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Assessment of safety and efficacy of volume-targeted ventilation in patients with neuromuscular disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Slowly progressive neuromuscular disease * Established on fixed bi-level ventilation * Documented clinical respiratory stability by supervising clinician (no hospitalizations, respiratory infections or change to ventilator settings in preceding 6 weeks) Exclusion Criteria: * Rapidly progressive neuromuscular disease * Decompensated respiratory failure (pH \< 7.35) * Pregnancy * Aged \<18, \>80 * Poor adherence to NIV (\<4hrs per night) * Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol
💊

What it tests

  • Volume-targeted non-invasive ventilation
📍

Where

2 sites
Guy's & St Thomas' NHS Foundation Trust
London, United Kingdom
Guy's and St. Thomas NHS Foundation Trust
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy